Progesterone and Breast Cancer: an NCI Workshop Report.
作者信息
Sathyamoorthy Neeraja, Lange Carol A
机构信息
Tumor Biology & Microenvironment Branch, Division of Cancer Biology, National Cancer Institute, Rockville, MD, USA.
Departments of Medicine and Pharmacology, Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
出版信息
Horm Cancer. 2020 Feb;11(1):1-12. doi: 10.1007/s12672-020-00379-1.
Abstract
摘要
相似文献
1
Progesterone and Breast Cancer: an NCI Workshop Report.孕酮与乳腺癌：美国国立癌症研究所研讨会报告
Horm Cancer. 2020 Feb;11(1):1-12. doi: 10.1007/s12672-020-00379-1.
2
The biology of hormone refractory breast and prostate cancer: An NCI workshop report.激素难治性乳腺癌和前列腺癌的生物学特性：NCI 研讨会报告。
Cancer Biol Ther. 2009 Nov;8(21):1975-85. doi: 10.4161/cbt.8.21.9918. Epub 2009 Nov 26.
3
Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers.在国立癌症研究所指定的癌症治疗中心，支付方协商的乳腺癌治疗价格。
Ann Surg Oncol. 2022 Jun;29(6):3381-3383. doi: 10.1245/s10434-022-11349-y. Epub 2022 Jan 29.
4
Determinants of NCI Cancer Center attendance in Medicare patients with lung, breast, colorectal, or prostate cancer.国立癌症研究所癌症中心对患有肺癌、乳腺癌、结直肠癌或前列腺癌的医疗保险患者就诊情况的影响因素
J Gen Intern Med. 2009 Feb;24(2):205-10. doi: 10.1007/s11606-008-0863-y. Epub 2008 Dec 6.
5
[Results of the EORTC/NCI Expert Meetings "HER2 diagnosis"].
Onkologie. 2002 Dec;25 Suppl 5:8-10.
6
Nutrition Education Services Described on National Cancer Institute (NCI)-Designated Cancer Center Websites.美国国立癌症研究所（NCI）指定的癌症中心网站上描述的营养教育服务。
J Cancer Educ. 2019 Oct;34(5):860-864. doi: 10.1007/s13187-018-1384-y.
7
Salivary oestradiol and progesterone levels in premenopausal women with breast cancer.
Eur J Cancer Clin Oncol. 1986 Apr;22(4):427-33. doi: 10.1016/0277-5379(86)90108-2.
8
Influence of NCI cancer center attendance on mortality in lung, breast, colorectal, and prostate cancer patients.美国国立癌症研究所癌症中心就诊对肺癌、乳腺癌、结直肠癌和前列腺癌患者死亡率的影响。
Med Care Res Rev. 2009 Oct;66(5):542-60. doi: 10.1177/1077558709335536. Epub 2009 May 19.
9
Joint NCI/SNMMI Workshop on Targeted Radionuclide Therapy.美国国立癌症研究所/核医学与分子影像学会靶向放射性核素治疗联合研讨会
J Nucl Med. 2013 May;54(5):16N-7.
10
Future opportunities in cancer nanotechnology--NCI strategic workshop report.癌症纳米技术的未来机遇——NCI 战略研讨会报告
Cancer Res. 2014 Mar 1;74(5):1307-10. doi: 10.1158/0008-5472.CAN-13-2787. Epub 2014 Jan 10.
引用本文的文献
1
The inhibitory effect of trastuzumab on BT474 triple‑positive breast cancer cell viability is reversed by the combination of progesterone and estradiol.曲妥珠单抗对BT474三阳性乳腺癌细胞活力的抑制作用被孕酮和雌二醇的联合使用所逆转。
Oncol Lett. 2023 Nov 15;27(1):19. doi: 10.3892/ol.2023.14152. eCollection 2024 Jan.
2
Upregulation of an estrogen receptor-regulated gene by first generation progestins requires both the progesterone receptor and estrogen receptor alpha.第一代孕激素通过雌激素受体调节基因的上调需要孕激素受体和雌激素受体α。
Front Endocrinol (Lausanne). 2022 Sep 15;13:959396. doi: 10.3389/fendo.2022.959396. eCollection 2022.
3
High Levels of Progesterone Receptor B in MCF-7 Cells Enable Radical Anti-Tumoral and Anti-Estrogenic Effect of Progestin.MCF-7细胞中高水平的孕激素受体B使孕激素具有显著的抗肿瘤和抗雌激素作用。
Biomedicines. 2022 Aug 2;10(8):1860. doi: 10.3390/biomedicines10081860.
4
Emerging roles of the HECT-type E3 ubiquitin ligases in hematological malignancies.HECT 型 E3 泛素连接酶在血液系统恶性肿瘤中的新作用。
Discov Oncol. 2021 Oct 8;12(1):39. doi: 10.1007/s12672-021-00435-4.
5
Application of an Assay to Identify Chemicals That Increase Estradiol and Progesterone Synthesis and Are Potential Breast Cancer Risk Factors.应用一种测定法来鉴定可增加雌二醇和孕酮合成的化学品，并确定其是否为潜在的乳腺癌风险因素。
Environ Health Perspect. 2021 Jul;129(7):77003. doi: 10.1289/EHP8608. Epub 2021 Jul 21.
6
Global mapping of cancers: The Cancer Genome Atlas and beyond.全球癌症图谱：癌症基因组图谱及其他。
Mol Oncol. 2021 Nov;15(11):2823-2840. doi: 10.1002/1878-0261.13056. Epub 2021 Jul 20.
本文引用的文献
1
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.绝经激素治疗的类型和时机与乳腺癌风险：全球流行病学证据的个体参与者荟萃分析。
Lancet. 2019 Sep 28;394(10204):1159-1168. doi: 10.1016/S0140-6736(19)31709-X. Epub 2019 Aug 29.
2
Glucocorticoid receptor quaternary structure drives chromatin occupancy and transcriptional outcome.糖皮质激素受体四级结构驱动染色质占据和转录结果。
Genome Res. 2019 Aug;29(8):1223-1234. doi: 10.1101/gr.244814.118. Epub 2019 Jul 23.
3
Progesterone Receptor Attenuates STAT1-Mediated IFN Signaling in Breast Cancer.孕激素受体在乳腺癌中减弱 STAT1 介导的 IFN 信号转导。
J Immunol. 2019 May 15;202(10):3076-3086. doi: 10.4049/jimmunol.1801152. Epub 2019 Apr 1.
4
Phosphorylated Progesterone Receptor Isoforms Mediate Opposing Stem Cell and Proliferative Breast Cancer Cell Fates.磷酸化孕激素受体异构体介导相反的乳腺癌干细胞和增殖细胞命运。
Endocrinology. 2019 Feb 1;160(2):430-446. doi: 10.1210/en.2018-00990.
5
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions.雌激素受体 α 阳性乳腺癌的导管内患者源性异种移植物再现了人类病变的组织病理学谱和转移潜能。
J Pathol. 2019 Mar;247(3):287-292. doi: 10.1002/path.5200. Epub 2018 Dec 27.
6
The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.甾体激素受体在乳腺导管原位癌（DCIS）中的新兴作用。
J Mammary Gland Biol Neoplasia. 2018 Dec;23(4):237-248. doi: 10.1007/s10911-018-9416-0. Epub 2018 Oct 18.
7
Comprehensive Phenotypic Characterization of Human Invasive Lobular Carcinoma Cell Lines in 2D and 3D Cultures.在 2D 和 3D 培养物中全面表型特征分析人类浸润性小叶癌细胞系。
Cancer Res. 2018 Nov 1;78(21):6209-6222. doi: 10.1158/0008-5472.CAN-18-1416. Epub 2018 Sep 18.
8
Biological and clinical impact of imbalanced progesterone receptor isoform ratios in breast cancer.乳腺癌中孕激素受体亚型比例失衡的生物学和临床影响
Endocr Relat Cancer. 2018 Jul 10. doi: 10.1530/ERC-18-0179.
9
Mammary molecular portraits reveal lineage-specific features and progenitor cell vulnerabilities.乳腺分子特征揭示了特定谱系的特征和祖细胞脆弱性。
J Cell Biol. 2018 Aug 6;217(8):2951-2974. doi: 10.1083/jcb.201804042. Epub 2018 Jun 19.
10
Progesterone receptor isoforms, agonists and antagonists differentially reprogram estrogen signaling.孕激素受体亚型、激动剂和拮抗剂对雌激素信号传导进行差异性重编程。
Oncotarget. 2017 Sep 28;9(4):4282-4300. doi: 10.18632/oncotarget.21378. eCollection 2018 Jan 12.
Zotero 插件